Charles River Laboratories has announced it's acquisition of Microgenetix, the premier provider of microbial identification services for biopharmaceutical, biotechnology, medical device, personal care, food, beverage, and dairy companies across Australia. With this acquisition, Charles River pairs the precision of DNA sequencing and MALDI-TOF mass spectrometry testing services with local access to the global Accugenix^® ID database and convenient data trending tools.

Foster Jordan, Corporate Senior Vice President of the Microbial Solutions business division of Charles River, commented, “This acquisition will enhance our position as the leading provider of microbial identification services by expanding our global geographic footprint. Charles River will have a new location in Australia, which will enable us to meet client demands by providing local testing services with rapid turnaround time.”